A tailor made molecule against malaria

(Université de Genève) The malaria parasite is particularly pernicious since it is built to develop resistance to treatments. The lack of new therapeutic approaches also contributes to the persistence of this global scourge. A study led by Didier Picard, professor at the Faculty of Sciences of the University of Geneva, Switzerland, describes a new class of molecules targeting the two problems at the same time.